223 related articles for article (PubMed ID: 29286149)
41. Anti-cancer and Sensibilisation Effect of Triptolide on Human Epithelial Ovarian Cancer.
Hu H; Luo L; Liu F; Zou D; Zhu S; Tan B; Chen T
J Cancer; 2016; 7(14):2093-2099. PubMed ID: 27877225
[No Abstract] [Full Text] [Related]
42. [Effect of MTRR gene on apoptosis and autophagy pathways in multiresistant epithelial ovarian cancer].
Chen J; Wang Q; Zhang W; Li L
Zhonghua Fu Chan Ke Za Zhi; 2016 Apr; 51(4):285-92. PubMed ID: 27116987
[TBL] [Abstract][Full Text] [Related]
43. The PI3K/AKT/mTOR pathway is a potential predictor of distinct invasive and migratory capacities in human ovarian cancer cell lines.
Bai H; Li H; Li W; Gui T; Yang J; Cao D; Shen K
Oncotarget; 2015 Sep; 6(28):25520-32. PubMed ID: 26267321
[TBL] [Abstract][Full Text] [Related]
44. Picropodophyllin inhibits epithelial ovarian cancer cells in vitro and in vivo.
Lu X; Wang L; Mei J; Wang X; Zhu X; Zhang Q; Lv J
Biochem Biophys Res Commun; 2013 Jun; 435(3):385-90. PubMed ID: 23665331
[TBL] [Abstract][Full Text] [Related]
45. Triptolide exerts anti-tumor effect on oral cancer and KB cells in vitro and in vivo.
Chen YW; Lin GJ; Chia WT; Lin CK; Chuang YP; Sytwu HK
Oral Oncol; 2009 Jul; 45(7):562-8. PubMed ID: 19359213
[TBL] [Abstract][Full Text] [Related]
46. miR-100 resensitizes resistant epithelial ovarian cancer to cisplatin.
Guo P; Xiong X; Zhang S; Peng D
Oncol Rep; 2016 Dec; 36(6):3552-3558. PubMed ID: 27748936
[TBL] [Abstract][Full Text] [Related]
47. Novel expression of CD11b in epithelial ovarian cancer: Potential therapeutic target.
Saed GM; Fletcher NM; Diamond MP; Morris RT; Gomez-Lopez N; Memaj I
Gynecol Oncol; 2018 Mar; 148(3):567-575. PubMed ID: 29329880
[TBL] [Abstract][Full Text] [Related]
48. LSR Antibody Therapy Inhibits Ovarian Epithelial Tumor Growth by Inhibiting Lipid Uptake.
Hiramatsu K; Serada S; Enomoto T; Takahashi Y; Nakagawa S; Nojima S; Morimoto A; Matsuzaki S; Yokoyama T; Takahashi T; Fujimoto M; Takemori H; Ueda Y; Yoshino K; Morii E; Kimura T; Naka T
Cancer Res; 2018 Jan; 78(2):516-527. PubMed ID: 29187404
[TBL] [Abstract][Full Text] [Related]
49. Anti-oral cancer effects of triptolide by downregulation of DcR3 in vitro, in vivo, and in preclinical patient-derived tumor xenograft model.
Yang CY; Lin CK; Hsieh CC; Tsao CH; Lin CS; Peng B; Chen YT; Ting CC; Chang WC; Lin GJ; Sytwu HK; Chen YW
Head Neck; 2019 May; 41(5):1260-1269. PubMed ID: 30537218
[TBL] [Abstract][Full Text] [Related]
50. Oridonin effectively reverses cisplatin drug resistance in human ovarian cancer cells via induction of cell apoptosis and inhibition of matrix metalloproteinase expression.
Ma S; Tan W; Du B; Liu W; Li W; Che D; Zhang G
Mol Med Rep; 2016 Apr; 13(4):3342-8. PubMed ID: 26935490
[TBL] [Abstract][Full Text] [Related]
51. The enhanced antitumor effects of biodegradable cationic heparin-polyethyleneimine nanogels delivering HSulf-1 gene combined with cisplatin on ovarian cancer.
Liu P; Gou M; Yi T; Qi X; Xie C; Zhou S; Deng H; Wei Y; Zhao X
Int J Oncol; 2012 Oct; 41(4):1504-12. PubMed ID: 22825572
[TBL] [Abstract][Full Text] [Related]
52. Prodrug polymeric micelles integrating cancer-associated fibroblasts deactivation and synergistic chemotherapy for gastric cancer.
Zheng S; Wang J; Ding N; Chen W; Chen H; Xue M; Chen F; Ni J; Wang Z; Lin Z; Jiang H; Liu X; Wang L
J Nanobiotechnology; 2021 Nov; 19(1):381. PubMed ID: 34802453
[TBL] [Abstract][Full Text] [Related]
53. Natural product triptolide induces GSDME-mediated pyroptosis in head and neck cancer through suppressing mitochondrial hexokinase-ΙΙ.
Cai J; Yi M; Tan Y; Li X; Li G; Zeng Z; Xiong W; Xiang B
J Exp Clin Cancer Res; 2021 Jun; 40(1):190. PubMed ID: 34108030
[TBL] [Abstract][Full Text] [Related]
54. Triptolide inhibits cell growth and GRP78 protein expression but induces cell apoptosis in original and radioresistant NPC cells.
Li C; Zhang B; Lv W; Lai C; Chen Z; Wang R; Long X; Feng X
Oncotarget; 2016 Aug; 7(31):49588-49596. PubMed ID: 27391061
[TBL] [Abstract][Full Text] [Related]
55. Triptolide ameliorates autoimmune diabetes and prolongs islet graft survival in nonobese diabetic mice.
Huang SH; Lin GJ; Chu CH; Yu JC; Chen TW; Chen YW; Chien MW; Chu CC; Sytwu HK
Pancreas; 2013 Apr; 42(3):442-51. PubMed ID: 23146919
[TBL] [Abstract][Full Text] [Related]
56. Anti-tumor effects of triptolide on angiogenesis and cell apoptosis in osteosarcoma cells by inducing autophagy via repressing Wnt/β-Catenin signaling.
Li X; Lu Q; Xie W; Wang Y; Wang G
Biochem Biophys Res Commun; 2018 Feb; 496(2):443-449. PubMed ID: 29330051
[TBL] [Abstract][Full Text] [Related]
57. LY2109761 enhances cisplatin antitumor activity in ovarian cancer cells.
Gao Y; Shan N; Zhao C; Wang Y; Xu F; Li J; Yu X; Gao L; Yi Z
Int J Clin Exp Pathol; 2015; 8(5):4923-32. PubMed ID: 26191185
[TBL] [Abstract][Full Text] [Related]
58. Triptolide augments the effects of 5-lipoxygenase RNA interference in suppressing pancreatic tumor growth in a xenograft mouse model.
Ding X; Zhou X; Zhang H; Qing J; Qiang H; Zhou G
Cancer Chemother Pharmacol; 2012 Jan; 69(1):253-61. PubMed ID: 21713446
[TBL] [Abstract][Full Text] [Related]
59. Triptolide inhibits benign prostatic epithelium viability and migration and induces apoptosis via upregulation of microRNA-218.
Yao C; Li H; Zhang W
Int J Immunopathol Pharmacol; 2018; 32():2058738418812349. PubMed ID: 30453799
[TBL] [Abstract][Full Text] [Related]
60. Effects of valproic acid on proliferation, apoptosis, angiogenesis and metastasis of ovarian cancer in vitro and in vivo.
Shan Z; Feng-Nian R; Jie G; Ting Z
Asian Pac J Cancer Prev; 2012; 13(8):3977-82. PubMed ID: 23098503
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
